U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. FDA Webinar: Draft GFI On Expedited Programs For Serious Conditions Drugs And Biologics - August 5, 2013
  1. Drugs

FDA Webinar: Draft GFI On Expedited Programs For Serious Conditions Drugs And Biologics - August 5, 2013

On August 5, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Expedited Programs For Serious Conditions Drugs And Biologics."

The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.

Questions may be submitted to docket so that they can be formally processed by FDA.

Draft GFI: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf

FR Notice: https://www.federalregister.gov/articles/2013/06/26/2013-15250/draft-guidance-for-industry-on-expedited-programs-for-serious-conditions-drugs-and-biologics

Docket No. FDA-2013-D-0575 which can be found at: www.regulations.gov

Date FR NOA: 06/26/2013

Comment Period Closes: 08/26/2013

PRESENTERS:
Stephanie Shapley
Health Science Policy Analyst
Office of Medical Policy
 
Brutrinia Cain
Regulatory Counsel
Office of Medical Policy

Presentation Information

Resources

If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm
Back to Top